Skip to content

Friday links

Wakefield lessons: Economist, Spiked on-line [plenty to take issue with there], and Evan Harris with the real questions that need addressing in the BMJ. | Orlistat weight-loss drug and liver disease FDA. | Simvastatin 80mg, the evidence NPC. | Mixed results on decriminalising dispensing errors PJ | Advanced Short Course in Pharmacoepidemiology at the LSHTM on 26 – 28 July 2010, some great speakers including Mike Rawlins from NICE.

Have a great weekend!

3 Comments

  1. Ken

    From memory the dose-response curve for simvastatin is almost flat at 40mg doses. There wasn’t any information at the time for 80mg and probably still isn’t a lot. So best guess is that 80mg does very little more, not enough to make it worth the side-effects.

    Posted on 29-May-10 at 11:10 am | Permalink
  2. wasn’t any information at the time for 80mg and probably still isn’t a

    Posted on 14-Jun-10 at 4:57 pm | Permalink
  3. I do not like Mike Rawlins at all ((

    Posted on 24-Aug-10 at 10:35 am | Permalink

Post a Comment

Your email is never published nor shared. Required fields are marked *
*
*